TipRanks
Go Ultimate55% OFF

Bicycle Therapeutics (BCYC) Stock Forecast & Price Target

418 Followers
See the Price Targets and Ratings of:

BCYC Analyst Ratings

Hold
2Ratings
0Buy2Hold0Sell
Based on 2 analysts giving stock ratings to Bicycle Therapeutics in the past 3 months

BCYC Stock 12 Month Forecast

$5.00▲(34.41% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Bicycle Therapeutics in the last 3 months. The average price target is $5.00 with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 34.41% change from the last price of $3.72.
Highest Price Target$5.00Average Price Target$5.00Lowest Price Target$5.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for BCYC
Price TargetFollowArticle
RBC Capital$5hold34.41%UpsideReiterated10/29/26
Morgan Stanley―hold―Reiterated08/17/26
Truist Financial$7hold88.17%UpsideReiterated07/31/26
Oppenheimer$36→$11buy195.70%UpsideInitiated07/31/26
Needham$15→$14buy276.34%UpsideReiterated07/30/26
TD Cowen―buy―Reiterated07/30/26
Jefferies$13→$12buy222.58%UpsideReiterated04/30/26
Citizens JMP$12→$8buy115.05%UpsideReiterated03/18/26
Barclays$15buy303.23%UpsideReiterated10/31/25
H.C. Wainwright$33buy787.10%UpsideReiterated10/31/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bicycle Therapeutics

3 Months
Reni Benjamin
Reni BenjaminCitizens JMP
Success Rate13/34 ratings generated profit
38%
Average Return
-5.05%

Copying Reni Benjamin's trades and holding each position for 3 Months would result in 38.24% of your transactions generating a profit, with an average return of -5.05% per trade.

1 Year
Reni Benjamin
Reni BenjaminCitizens JMP
Success Rate8/34 ratings generated profit
24%
Average Return
-27.01%

Copying Reni Benjamin's trades and holding each position for 1 Year would result in 23.53% of your transactions generating a profit, with an average return of -27.01% per trade.

2 Years
Peter Lawson
Peter LawsonBarclays
Success Rate1/16 ratings generated profit
6%
Average Return
-62.92%

Copying Peter Lawson's trades and holding each position for 2 Years would result in 6.25% of your transactions generating a profit, with an average return of -62.92% per trade.

BCYC Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for BCYC
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy54220
Buy11110
Hold44332
Sell00000
Strong Sell00000
total109662

In the current month, BCYC has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BCYC average Analyst price target in the past 3 months is 5.00.

BCYC Financial Forecast

$-2$-1.25$-0.5$0.25$1Q1 2026Q3 2026Q4 2026
High$0.28
Consensus$-0.44
Low$-0.70

BCYC Earnings Forecast

Next quarter’s earnings estimate for BCYC is -$0.44 with a range of -$0.70 to $0.28. The previous quarter’s EPS was -$0.15. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$199,999$12.1M$24M$36M$47.9MQ1 2026Q3 2026Q4 2026
High$14.4M
Consensus$2.47M
Low$200K

BCYC Sales Forecast

Next quarter’s sales forecast for BCYC is $2.47M with a range of $200.00K to $14.40M. The previous quarter’s sales results were $34.04M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

BCYC Stock Forecast FAQ

What is BCYC’s average 12-month price target, according to analysts?
Based on analyst ratings, Bicycle Therapeutics’s 12-month average price target is $5.00.
What is BCYC’s upside potential, based on the analysts’ average price target?
Bicycle Therapeutics has 34.41% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BCYC a Buy, Sell or Hold?
Bicycle Therapeutics has a consensus rating of Hold which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What is Bicycle Therapeutics’s price target?
The average price target for Bicycle Therapeutics is $5.00. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $5.00, the lowest forecast is $5.00. The average price target represents a 34.41% increase from the current price of $3.72.
What do analysts say about Bicycle Therapeutics?
Bicycle Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of BCYC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.